Jenny Huanjiao Zhou, MD, PhD

Jenny Huanjiao Zhou got both M.D. and Ph.D. degree from Sun Yat-sen University in China. Specifically, Dr. Zhou got her doctoral degree in Ophthalmic specialty from Zhongshan Ophthalmic center (the best ophthalmic hospital and research center in China) at Sun Yat-sen University and was joint-trained as China’s Scholarship Council sponsored postgraduate at Yale. She has finished post-doctoral training in vascular biology at the Department of Pathology, Yale School of Medicine. Dr. Zhou has strong interests in cardiovascular and retinal disease, including endothelial signaling and biology, vascular malformation and remodeling. Her goal is to dissect the molecular mechanisms for angiogenesis and vasculogenesis and facilitate new therapeutic strategies for vascular diseases. For example, she has established inducible endothelial-specific CCM3 mouse model for human cerebral cavernous malformation (CCM) disease and have intriguingly found that blockade of exocytosis or inhibition of Angiopoietin2-Tie2 signaling completely blunts CCM lesion formation in the mouse model (Zhou HJ, et al, Nat Med, 2016; Nat Commun, 2021). This work has greatly encouraged CCM patients with the hope of saving life. Dr. Zhou is a member of NAVBO, AHA, and Yale Stem Cell Center. She has been the recipient of many awards, including the Asia-ARVO meeting’s Full Travel Fellowship Grant Award (Singapore, 2011), Angioma Alliance’s Full Trainee Travel Award (Award Lecture in 2014 and 2016), Best Poster Award for Postdoctoral Category at 16^th Annual Retreat of Vascular Biology & Therapeutics Center at Yale (2016), American Heart Association (AHA) Postdotoral Fellowship Award (2017), AHA Career Development Award (2019), NIH Grant Award (2021).